FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Cancers · 07.04.2025 · 17 (7) · 1249
DOI: 10.3390/cancers17071249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 07.04.2025. Verfasst von David Groheux und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, AP-HP, Saint-Louis Hospital, F-75010 Paris, France. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National du Cancer, French national cancer institute.
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
Purpose
Triple-negative breast cancer (TNBC) is a biologically and clinically heterogeneous disease, associated with poorer outcomes when compared with other subtypes of breast cancer. Neoadjuvant chemotherapy (NAC) is often given before surgery, and achieving a pathological complete response (pCR) has been associated with patient outcomes. There is thus strong clinical interest in the ability to accurately predict pCR status using baseline data. Materials and Methods: A cohort of 57 TNBC patients who underwent FDG-PET/CT before NAC was analyzed to develop a machine learning (ML) algorithm predictive of pCR. A total of 241 predictors were collected for each patient: 11 clinical features, 11 histopathological features, 13 genomic features, and 206 PET features, including 195 radiomic features. The optimization criterion was the area under the ROC curve (AUC). Event-free survival (EFS) was estimated using the Kaplan–Meier method.
Results
The best ML algorithm reached an AUC of 0.82. The features with the highest weight in the algorithm were a mix of PET (including radiomics), histopathological, genomic, and clinical features, highlighting the importance of truly multimodal analysis. Patients with predicted pCR tended to have a longer EFS than patients with predicted non-pCR, even though this difference was not significant, probably due to the small sample size and few events observed (p = 0.09).
Conclusions
This study suggests that ML applied to baseline multimodal data can help predict pCR status after NAC for TNBC patients and may identify correlations with long-term outcomes. Patients predicted as non-pCR may benefit from concomitant treatment with immunotherapy or dose intensification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, AP-HP, Saint-Louis Hospital, F-75010 Paris, France.
- Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris, France.
- SOPHiA GENETICS, F-33600 Pessac, France.
- Molecular Oncology Unit, AP-HP, Saint Louis Hospital, F-75010 Paris, France.
- Breast Diseases Unit, AP-HP, Saint Louis Hospital, F-75010 Paris, France.
- SOPHiA GENETICS, 1180 Rolle, Switzerland.
ORCID-Profile: Loïc Ferrer, Jacqueline Lehmann-Che
Förderung
- Institut National du Cancer
- French national cancer institute
Zitieren
APA
Groheux, D., Ferrer, L., Vargas, J., Martineau, A., Borgel, A., Teixeira, L., Menu, P., Bertheau, P., Gallinato, O., Colin, T., & Lehmann-Che, J. (2025). FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers, 17(7), 1249. https://doi.org/10.3390/cancers17071249
Vancouver
Groheux D, Ferrer L, Vargas J, Martineau A, Borgel A, Teixeira L, et al. FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers. 2025;17(7):1249. doi:10.3390/cancers17071249
BibTeX
@article{Groheux2025,
author = {Groheux, David and Ferrer, Loïc and Vargas, Jennifer and Martineau, Antoine and Borgel, Adrien and Teixeira, Luis and Menu, Philippe and Bertheau, Philippe and Gallinato, Olivier and Colin, Thierry and Lehmann-Che, Jacqueline},
title = {FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {7},
pages = {1249},
doi = {10.3390/cancers17071249}
}
EUVIMED